Elite Pharmaceuticals PEG Ratio

Elite Pharmaceuticals (ELTP) currently reports a PEG ratio of 107.21. That is above the Healthcare sector average of 1.26. Use the charts on this page to explore Elite Pharmaceuticals's PEG ratio history and peer comparisons.

Elite Pharmaceuticals's PEG ratio of 107.21 is higher than the Healthcare sector average of 1.26. That is roughly 8427.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Elite Pharmaceuticals's market price to a fundamental measure such as earnings, sales, or book value. At 107.21, ELTP can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 107.21, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 1.26. From there, open related valuation or income-statement pages for Elite Pharmaceuticals, and consider following ELTP for alerts when major investors trade the stock.

Elite Pharmaceuticals is classified in the Healthcare sector. On PEG ratio, it currently shows 107.21 versus a sector average near 1.26. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ELTP with unrelated industries.